Jørgen Buus Lassen
Director/Board Member at Effector A/S
Network origin in Jørgen Buus Lassen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
24
| Public Company | Pharmaceuticals: Major | 24 |
| Public Company | Trucking | 20 | |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark.
7
| Extinct | Pharmaceuticals: Major | 7 |
Collegium Internationale Neuro-Psychopharmacologicum
4
| Non-Profit Organization | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jørgen Buus Lassen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Bok Holding A/S
 Bok Holding A/S BiotechnologyHealth Technology Bok Holding A/S is a holding company that operates as a biotechnology company that researches and develops cancer treatment solutions. It develops the ZAS platform technology which efficiently enhances the effect of current anti-cancer drugs and reduces toxicity. The firm employs molecular techniques commonly known as molecular breeding or directed enzyme evolution which can activate anti-cancer drugs. The company was founded by Zoran Gojkovic on November 22, 2001 and is headquartered in Gentofte, Denmark. | Biotechnology | Director/Board Member Director/Board Member Chairman Chairman | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Sophion Bioscience A/S
 Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Medical Specialties | Corporate Officer/Principal Chairman Chairman | |
| Astra Research Centre AB | Chairman Chief Tech/Sci/R&D Officer | ||
| GENMAB A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
| INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Relivia SRL
 Relivia SRL Household/Personal CareConsumer Non-Durables Relivia SRL manufactures cosmetic products. The private company is based in Milan, Italy. | Household/Personal Care | Chairman Corporate Officer/Principal | |
| NEOS AB | Medical Specialties | Chairman Director/Board Member | |
| RECORDATI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Milan | College/University | Undergraduate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| TRANSGENE | Biotechnology | Director/Board Member Director/Board Member | |
| ALK-ABELLÓ A/S | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| NANEXA AB | Medical Specialties | Chairman Director/Board Member | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Ferrosan ApS
 Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Aarhus | College/University | Doctorate Degree Doctorate Degree | |
| VALERITAS INC | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Uppsala | College/University | Undergraduate Degree Graduate Degree | |
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Aberdeen | College/University | Undergraduate Degree Doctorate Degree | |
Origio A/S
 Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Biotechnology | Director/Board Member Chairman | |
| PHOTOCURE ASA | Medical Specialties | Director/Board Member Director/Board Member | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member Founder | |
Azign Bioscience AS
 Azign Bioscience AS BiotechnologyHealth Technology Part of Atonomics A/S, Azign Bioscience AS is a biotechnology company based in Copenhagen, Denmark. The Danish company provides biotechnology services. Azign Bioscience was acquired by Atonomics A/S from NTG Nordic Transport Group A/S on June 30, 2004. | Biotechnology | Director/Board Member Chairman | |
| University of Western Ontario | College/University | Doctorate Degree Masters Business Admin | |
| OREXO AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| SANA AB | Biotechnology | Founder Founder | |
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member |
Statistics
International
| Denmark | 20 |
| United States | 10 |
| Sweden | 9 |
| France | 5 |
| Italy | 4 |
Sectoral
| Health Technology | 35 |
| Consumer Services | 10 |
| Commercial Services | 4 |
| Electronic Technology | 2 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 318 |
| Corporate Officer/Principal | 131 |
| Chairman | 114 |
| Chief Executive Officer | 59 |
| Founder | 56 |
Most connected contacts
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Jean-Luc Bélingard | 40 |
| Mette Agger | 30 |
| Birgit Stattin Norinder | 29 |
| Jørgen Hansen | 29 |
| Torbjørn Bjerke | 27 |
| Vaughn M. Kailian | 27 |
| Jørgen Drejer | 26 |
| Peter Andersen | 26 |
| Flemming Heise Pedersen | 24 |
| Mats Gunnar Pettersson | 23 |
| Frank Baldino | 23 |
| Elizabeth Marie Robinson | 22 |
| Thomas Hofman-Bang | 22 |
| Damian Marron | 21 |
- Stock Market
- Insiders
- Jørgen Buus Lassen
- Company connections
